The upfront investment needed to make artificial intelligence (AI) and machine learning (ML) viable in the pharmaceutical sector will be worth it.
This is a companion discussion topic for the original entry at https://www.ajmc.com/view/how-ai-and-machine-learning-can-bring-quality-improvements-in-biopharma